Ecological momentary assessment (EMA) reveals how people experience hearing challenges beyond the clinic. Here, researchers highlight its relevance in designing real-world hearing studies.
- New Imaging Approach Could Improve IPF Trial Design
- Most Patients Learn About A Trial Online, But Is That What They Want?
- How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy
- Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- How Digital Twins Are Reshaping Clinical R&D
- Why Are We Still Talking About Compensating Research Participants?
GUEST COLUMNISTS
-
![two same digital person-GettyImages-964835390]( "How Digital Twins Are Reshaping Clinical R&D")
How Digital Twins Are Reshaping Clinical R&DDiscover how digital twins are helping predict outcomes, streamline recruitment, reduce patient burden, and accelerate clinical development.
-
![hand holding credit card, laptop-GettyImages-2207149857]( "Why Are We Still Talking About Compensating Research Participants?")
Why Are We Still Talking About Compensating Research Participants?Should we be compensating research participants? And is that even a question worth asking? Lindsay McNair, MD, and Ken Getz say yes despite recent data that doesn't point to a clear ROI.
-
![Senior woman meeting with doctor-GettyImages-2205398466]( "Examining The Potential Of P-tau217 To Provide Earlier Diagnosis Of Alzheimer's")
Examining The Potential Of P-tau217 To Provide Earlier Diagnosis Of Alzheimer'sP-tau217 blood tests could accelerate Alzheimer’s diagnosis. Lilly’s Nino Sireci, MD, MSc, explains the research, evidence thus far, potential clinical use, and next steps.
-
![stack of clipped documents-GettyImages-2213243327]( "The 50-Page Monitoring Report And The Illusion Of Control")
The 50-Page Monitoring Report And The Illusion Of ControlA massive decentralized trial showed why more monitoring doesn’t always mean more control — and how risk-based oversight can reveal what truly matters.
-
![International Womans Day-GettyImages-2259815511]( "Autoimmune Drugs For Women: What To Bring To The Clinic")
Autoimmune Drugs For Women: What To Bring To The ClinicAutoimmune disease is one of the most sex-skewed categories in medicine. Sex, reproductive status, and hormonal state should not be treated as background noise.
-
![site contract-gettyimages-2267854910]( "The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect")
The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is SuspectStarting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.
-
![Lab Experiment-GettyImages-157697835]( "The U.S. Clinical Trial Recruiting Pipeline Report – August 2026")
The U.S. Clinical Trial Recruiting Pipeline Report – August 2026This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from July and August.
-
![elderly care, rehabilitation, recovery-GettyImages-2274991410]( "How VNS-REHAB Aims To Improve Stroke Recovery After Patients Have Plateaued")
How VNS-REHAB Aims To Improve Stroke Recovery After Patients Have PlateauedLearn how a stroke trial standardized intensive therapy, sustained patient adherence, and exposed access barriers after FDA approval.
CLINICAL TRIAL WHITE PAPERS
-
![meeting teamwork planning-GettyImages-2148861850]( "Designing More Representative Trials Through Strategic Planning")
Designing More Representative Trials Through Strategic PlanningStrategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
-
Automated Evidence Generation For Regulatory-Grade RWD10/20/2025
Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.
-
Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations8/20/2026
Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.
-
The Rapid Digitization Of Trials11/7/2024
It’s no secret that more trials are going digital. Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.
-
State Of Clinical Trial Technology: The AI Inflection Point2/12/2026
Digital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.
-
Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development9/8/2026
Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
What Unified eCOA And IRT Can Unlock4/6/2026
See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.
-
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy3/12/2026
Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.
-
Transforming European Case Intake Operations5/26/2026
Centralized intake and semi‑automation brought clarity and control to European safety reporting, improving oversight, data quality, and compliance across multiple partners and countries.
-
Increasing Efficiency And Reducing Drug Waste10/2/2025
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments1/29/2025
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia4/11/2025
Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
NEWSLETTER ARCHIVE
- 10.05.26 -- Why Are We Still Talking About Compensating Research Participants?
- 10.02.26 -- Sponsors Are Automating Trials With AI — But Can They Trust The Output?
- 10.01.26 -- Health Policy Is Shifting Fast — Is Your Compliance Strategy Keeping Pace?
- 10.01.26 -- Better Site Support Starts Early
- 09.30.26 -- Old Trial Playbooks Are Breaking Under New Complexity
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![Mature student Studying-GettyImages-1460342076]( "Most Patients Learn About A Trial Online, But Is That What They Want?")
Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.
-
![hand holding credit card, laptop-GettyImages-2207149857]( "Why Are We Still Talking About Compensating Research Participants?")
Should we be compensating research participants? And is that even a question worth asking? Lindsay McNair, MD, and Ken Getz say yes despite recent data that doesn't point to a clear ROI.
-
![International Womans Day-GettyImages-2259815511]( "Autoimmune Drugs For Women: What To Bring To The Clinic")
Autoimmune disease is one of the most sex-skewed categories in medicine. Sex, reproductive status, and hormonal state should not be treated as background noise.
FOCUS ON PATIENTS
-
![Mature student Studying-GettyImages-1460342076]( "Most Patients Learn About A Trial Online, But Is That What They Want?")
Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.
-
![Healthcare, Medical service, Health insurance-GettyImages-2191629470]( "How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy")
As the NIH shapes its plain language summary policy, EU CTR experience offers practical lessons on clarity, privacy, consistency, and implementation.
-
![hand holding credit card, laptop-GettyImages-2207149857]( "Why Are We Still Talking About Compensating Research Participants?")
Should we be compensating research participants? And is that even a question worth asking? Lindsay McNair, MD, and Ken Getz say yes despite recent data that doesn't point to a clear ROI.
